Overview

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Status:
Unknown status
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
Open label clinical randomized trial comparing three strategies for managing acute intermediate-high risk pulmonary embolism
Phase:
Phase 3
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborators:
Copenhagen University Hospital, Hvidovre
Herlev and Gentofte Hospital
Hillerod Hospital, Denmark
University Hospital Bispebjerg and Frederiksberg
Treatments:
Calcium heparin
Heparin
Tissue Plasminogen Activator